Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data

Biological disease-modifying antirheumatic drugs (bDMARDs) monotherapy may enhance adherence and decrease adverse events compared to combination therapy with conventional synthetic DMARDs (csDMARDs); however, persistence with bDMARD monotherapy has not been extensively studied. We explore persistenc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rheumatol Int
Main Authors: Pappas, Dimitrios A., Litman, Heather J., Lesperance, Tamara, Kricorian, Greg, Karis, Elaine, Rebello, Sabrina, Hua, Winnie, Accortt, Neil A., Stryker, Scott
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Observational Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7835165/
https://ncbi.nlm.nih.gov/pubmed/32876744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00296-020-04667-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados